News LifeArc rare disease programme to invest £100m improving pat... Self-funded, non-profit medical research organisation and charity LifeArc has announced today that it is to launch the Rare Disease Translational Challenge, which will inv
R&D AI could provide breakthrough for early diagnosis of rare di... For people living with rare diseases, one of the major challenges is being able to receive a rapid and accurate diagnosis.
R&D Sponsored Trials and tribulations of drug development: What does it ta... Rare diseases are a complex and challenging area of medicine, affecting millions of people worldwide.
R&D Making accessibility strategy part of your rare disease tria... Over the past several years, diversity, equity, and inclusion (DEI) has become a central subject of conversation in clinical trials.
Patients Challenges and opportunities with plasma-derived therapies This newest pharmaphorum podcast welcomes Takeda's Dr Kristina Allikmets.
R&D Sponsored Trials and tribulations of drug development What does it take to establish new treatments for rare diseases?
News ESC26: Can Arrowhead pierce Ionis' triglyceride armour? Arrowhead Pharma is squaring up to rival Ionis in the severe hypertriglyceridaemia (sHTG) market, drawing on phase 3 data at ESC 2026.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.